Read the fall 2022 edition of DiversiTEA Corner, the newsletter about inclusion, diversity, equity and accessibility at the UT College of Pharmacy. This semester’s topics include New Student Orientation, transgender and gender-nonconforming healthcare, National Hispanic Heritage Month, patients with Sickle Cell Disease, and many more.
This year, college welcomes Daniel San Miguel and Adriana Vargus through the BOOT program, providing a generous 12-month stipend plus paid tuition for the first academic year in order to to increase the recruitment, retention and preparation of trainees from diverse backgrounds.
This summer, the office of Diversity, Equity, Accessibility, and Inclusion (DEAI), hosted two intensive summer research programs: Project Engage Pharmacy Program (PEPP) Camp and the Leadership Through Engagement For the Advancement of Diverse Educational Research (LEADER) Program.
Researchers in UT Pharmacy's Pharmaceutical Engineering and 3D Printing (PharmE3D) Labs have earned a bevy of national and international awards for their work in pharmaceutical drug delivery and 3D printing personalized medicines.
Read the spring 2022 edition of DiversiTEA Corner, the newsletter about inclusion, diversity, equity and accessibility at the UT College of Pharmacy. This semester’s topics include the college's Dr. Carolyn Brown DEAI Champion Award recipients, a message from Pharmacy Council's DEAI chair, a university three-part series on midwives hosted by UT Pharmacy, our newest member of the DEAI team, and many more.
Pharmacy schools across the country completed their 2022 Phase I and Phase II residency matches for new or upcoming graduates of their Doctor of Pharmacy (Pharm.D.) programs. The University of Texas at Austin College of Pharmacy placed in the top ten of all pharmacy schools in the nation, and number one in Texas.
Dr. Mo Maniruzzaman's Pharmaceutical Engineering and 3D Printing Labs have received a federal grant from the United States Agency for International Development (USAID) to develop personalized 3D printed non-hormonal intrauterine devices (IUDs). The project’s goal is to increase global access to long-term and effective contraception while minimizing some of its most debilitating side effects.
These DEAI Champions have demonstrated exceptional efforts and continue to make significant contributions to creating a more diverse, equitable, accessible and inclusive culture within the college and beyond through their excellent service, teaching, research and/or academic endeavors.
The College of Pharmacy’s Pharmaceutical Engineering and 3D Printing (PharmE3D) Labs recently earned a three-year $1.5 million National Institutes of Health (NIH) R01 grant to research novel manufacturing technology for complex vaccine formulations for influenza and other emerging infectious diseases.
